Ranjana H. Advani, MD

home / authors / ranjana-h-advani-md

Articles

Current Frontline Treatment of Diffuse Large B-Cell Lymphoma

Michael A. Spinner, MD;Ranjana H. Advani, MD

January 20th 2022

This review article discusses which frontline treatment are best for diffuse large B-cell lymphoma.

Bulky Mediastinal Classical Hodgkin Lymphoma in Young Women

Mary-Elizabeth M. Percival, MD;Richard T. Hoppe, MD;Ranjana H. Advani, MD

March 16th 2014

Although the cure rate remains high in women who present with bulky mediastinal stage I–II HL, the challenge remains to balance efficacy and minimize long-term toxicities.

ACR Appropriateness Criteria® Localized Nodal Indolent Lymphoma

Bradford S. Hoppe, MD, MPH;David C. Hodgson, MD;Ranjana H. Advani, MD;Bouthaina S. Dabaja, MD;Christopher R. Flowers, MD, MS;Chul Soo Ha, MD;Monika L. Metzger, MD;John P. Plastaras, MD, PhD;Kenneth B. Roberts, MD;Ronald Shapiro, MD;Stephanie A. Terezakis, MD;Karen M. Winkfield, MD, PhD;Anas Younes, MD;Louis S. Constine, MD

August 15th 2013

The present guidelines review epidemiology, pathology, presentation, workup, staging, prognostic factors, and treatment options for patients with localized nodal indolent lymphoma, with an emphasis on radiation guidelines, including radiation dose, field design, and radiation techniques.